meclofenamic acid has been researched along with candesartan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abassi, RA; Bivalacqua, TJ; Champion, HC; Kadowitz, PJ; Lambert, DG | 1 |
1 review(s) available for meclofenamic acid and candesartan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for meclofenamic acid and candesartan
| Article | Year |
|---|---|
Analysis of vasoconstrictor responses to histamine in the hindlimb vascular bed of the rabbit.
Topics: Adamantane; Adrenergic alpha-Antagonists; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Vessels; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Hindlimb; Histamine; Injections, Intravenous; Male; Meclofenamic Acid; Morpholines; NG-Nitroarginine Methyl Ester; Phentolamine; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Histamine; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents | 1999 |